1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,810 | 2,110 | 15:29 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.02. | Careium AB: Careium reports fourth quarter results 2025 | 215 | GlobeNewswire (Europe) | Summary fourth quarter 2025Net sales increased by 0.9 percent to SEK 230.9 million (228.9)Net sales increased by 6.3 percent adjusted for currency effectsNet sales increased by 13.1 percent adjusted... ► Artikel lesen | |
| 11.12.25 | Careium AB: Careium comments on full-year results | 164 | GlobeNewswire (Europe) | Careium's operations are developing well, however we are currently experiencing longer sales cycles than expected in UK and Germany for product sales. This impacts net sales, profitability and cashflow.... ► Artikel lesen | |
| 02.12.25 | Careium AB: Tove Christiansson appointed CEO of Careium | 216 | GlobeNewswire (Europe) | The Board of Directors of Careium has appointed Tove Christiansson as the CEO, effective Q2 2026. She succeeds interim CEO Peter Heuman, who will remain in his current role until the transition has... ► Artikel lesen | |
| CAREIUM Aktie jetzt für 0€ handeln | |||||
| 24.10.25 | Careium AB: Careium reports third quarter results 2025 | 156 | GlobeNewswire (Europe) | The third quarter in summaryNet sales increased by 6.0 percent to SEK 213.7 million (201.7)Net sales increased by 9.4 percent adjusted for currency effectsNet sales increased despite a negative impact... ► Artikel lesen | |
| 18.08.25 | Careium AB: President & CEO Christian Walén steps down from his position and Peter Heuman appointed as interim CEO | 353 | GlobeNewswire (Europe) | Careium's Board of Directors and Careium's President and CEO Christian Walén have mutually agreed that Christian Walén steps down from the role of President and CEO, effective immediately.
"The Board... ► Artikel lesen | |
| 11.07.25 | Careium AB: Careium reports second quarter results 2025 | 226 | GlobeNewswire (Europe) | The second quarter in summary
Net sales decreased 11.9 percent to SEK 202.1 million (229.4)Reported net sales was negatively impacted with SEK 15.1 million by the accounting of financial leases in Sweden... ► Artikel lesen | |
| 13.06.25 | Careium AB: Bulletin from the extraordinary general meeting on 13 June 2025 of Careium AB (publ) | 190 | GlobeNewswire (Europe) | The extraordinary general meeting ("EGM") of Careium AB (publ), 559121-5875, (the "Company") took place today, 13 June 2025.
The EGM resolved on all proposed matters in accordance with previously published... ► Artikel lesen | |
| 24.04.25 | Careium AB: Careium reports first quarter results 2025 | 170 | GlobeNewswire (Europe) | The First Quarter in Summary
Net sales decreased 1.6 percent to SEK 207.4 million (210.7)Service sales increased 3.4 percent to SEK 160.3 million (155.0)Product sales decreased 15.5 percent to SEK 47.1... ► Artikel lesen |
8 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,130 | +1,12 % | EQS-DD: Fresenius SE & Co. KGaA: Michael Sen, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
06.03.2026 / 10:45... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,980 | -0,13 % | Siemens Healthineers: Drei Belastungen | Am 7. Mai wird Siemens Healthineers Zahlen zum zweiten Quartal publizieren. Die Analysten der DZ Bank glauben, dass diese schwach ausfallen werden. Drei Aspekte belasten derzeit die Daten: Die US-Zölle... ► Artikel lesen | |
| THERMO FISHER | 410,90 | -0,68 % | Dividendenbekanntmachungen (13.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIAN ASSET MANAGEMENT INC US10948W1036 0,1 USD 0,0868 EUR ALBEMARLE CORPORATION US0126531013 0,405 USD 0,3516 EUR ALEXANDRIA... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 61,58 | +0,62 % | Eurofins Biomnis führt eine neue klinische LC-MS/MS-Methode zum Nachweis von Cereulid-Toxin in Stuhlproben ein | Eurofins Biomnis, ein führender europäischer Anbieter von spezialisierten klinischen Diagnostikdienstleistungen, der zum globalen Netzwerk der Eurofins-Labore gehört, kündigt die erfolgreiche Entwicklung... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| DAVITA | 135,00 | +1,66 % | DaVita tops chart as the only large-cap healthcare services name rated Strong Buy | ||
| DENTSPLY SIRONA | 10,000 | -2,82 % | Dentsply Sirona: First-ever Dental Dedicated MRI System Validated In Trial, Cleared By FDA | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Dentsply Sirona (XRAY) and Siemens Healthineers (SHL.DE) announced that the dental-dedicated ddMRI system - MAGNETOM Free.Max Dental Edition - has received... ► Artikel lesen | |
| SMITH & NEPHEW | 14,525 | +0,45 % | Smith & Nephew Plc: Smith+Nephew launches next-generation ALLEVYN COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention | Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, recently announced the launch of ALLEVYN? COMPLETE CARE Foam Dressing, featuring proprietary technologies and performance backed... ► Artikel lesen | |
| SONIC HEALTHCARE | 12,746 | -0,98 % | SONIC HEALTHCARE LIMITED: Change of Director's Interest Notice | ||
| DIASORIN | 63,84 | -1,05 % | Milan: DiaSorin in the red | ||
| FULGENT GENETICS | 13,000 | +1,56 % | Fulgent Genetics forecasts $350M 2026 revenue and 53% AP growth as Bako, StrataDx acquisitions reshape customer mix | ||
| IMPLANTICA | 3,755 | -0,27 % | Implantica AG: Implantica publishes Year-end Report, January - December 2025 (Q4) | RefluxStop® US Launch Coming Closer, pending FDA approval
Significant events in the fourth quarter
FDA completed six pre-approval inspections during the quarter - including manufacturing sites,... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 4,620 | +4,05 % | Perspective Therapeutics, Inc.: Perspective Therapeutics to Provide Business Highlights and Report Full Year 2025 Financial Results | SEATTLE, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments... ► Artikel lesen | |
| OMNICELL | 30,400 | +0,66 % | Benchmark reiterates Omnicell stock rating on product cycle outlook | ||
| LEVITEE LABS | 0,010 | -100,00 % | CSE Bulletin: Delist - Levitee Labs Inc. (LVT) | Toronto, Ontario--(Newsfile Corp. - Le 26 janvier/January 2026) - The common shares of Levitee Labs Inc. will be delisted from the CSE at market close today, January 26, 2026. Levitee Labs... ► Artikel lesen |
CAREIUM AB gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -0,85 % bei einem Aktienkurs von 1,745 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CAREIUM AB finden Sie auf Wallstreet Online.